---
title: "tpextreme"
date: "2024-09-28"
tags:
  - building
---

> [!NOTE]
> üå± created from: [[palliative_intent-of-hnscc]]

# tpextreme

> 1.Guigay J, Aup√©rin A, Fayette J, et al. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. The Lancet Oncology. 2021;22(4):463-475. doi:10.1016/S1470-2045(20)30755-5
